We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

2 hedge funds and large institutions have $3.44M invested in Albany Molecular Research Inc in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 133 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 136 → 2 (-134)

99% less capital invested

Capital invested by funds: $677M → $3.44M (-$674M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 133

Holders
2
Holders Change
-134
Holders Change %
-98.53%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
133
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$871K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$80M
2
ACM
American Capital Management
New York
-$55.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$52M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$33.9M
5
Citigroup
Citigroup
New York
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
51
Ranger Investment Management
Texas
– -$2.25M -103,770 Closed
Charles Schwab
52
Charles Schwab
California
– -$2.21M -101,876 Closed
DCM
53
Dupont Capital Management
Delaware
– -$2.13M -98,208 Closed
WRBC
54
W.R. Berkley Corp
Connecticut
– -$2.1M -96,890 Closed
GH
55
GAM Holding
Switzerland
– -$2.06M -95,000 Closed
California Public Employees Retirement System
56
California Public Employees Retirement System
California
– -$2.06M -94,900 Closed
Bessemer Group
57
Bessemer Group
New Jersey
– -$1.98M -91,110 Closed
Invesco
58
Invesco
Georgia
– -$1.76M -81,300 Closed
O
59
OppenheimerFunds
New York
– -$1.68M -77,496 Closed
TCIM
60
TIAA CREF Investment Management
New York
– -$1.51M -69,609 Closed
Voloridge Investment Management
61
Voloridge Investment Management
Florida
– -$1.34M -61,962 Closed
Walleye Trading
62
Walleye Trading
New York
– -$1.3K -60,117 Closed
HK
63
Horizon Kinetics
New York
– -$1.22M -56,000 Closed
PCM
64
Proxima Capital Management
New York
– -$1.08M -49,755 Closed
GCIA
65
Gabelli & Co Investment Advisers
New York
– -$1.06M -48,859 Closed
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
– -$1.05M -48,218 Closed
SG Americas Securities
67
SG Americas Securities
New York
– -$1.03M -47,443 Closed
TA
68
Teachers Advisors
New York
– -$1.01M -46,562 Closed
Swiss National Bank
69
Swiss National Bank
Switzerland
– -$996K -45,900 Closed
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
– -$996K -45,896 Closed
GC
71
Guggenheim Capital
Illinois
– -$966K -44,419 Closed
Two Sigma Advisers
72
Two Sigma Advisers
New York
– -$948K -43,700 Closed
Legal & General Group
73
Legal & General Group
United Kingdom
– -$897K -41,310 Closed
Bank of Nova Scotia
74
Bank of Nova Scotia
Ontario, Canada
– -$848K -39,090 Closed
KeyBank National Association
75
KeyBank National Association
Ohio
– -$830K -38,263 Closed
1 2
3
4 5

AMRI Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2017, worth a combined $3.44M — down 99% from $677M a quarter earlier.

Sellers outnumbered buyers: 133 funds closed out of AMRI and 0 opened new positions — a net loss of 133 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Ancora Advisors, adding an estimated $871K. The largest seller was BlackRock, exiting entirely with an estimated $80M sold.

  • 2 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $3.44M of Albany Molecular Research Inc stock for Q3 2017, down 99% quarter-over-quarter.
  • 0 funds opened new Albany Molecular Research Inc positions in Q3 2017 and 133 closed out, a net change of -133 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2017 was Ancora Advisors, an estimated $871K added.
  • The largest Albany Molecular Research Inc seller in Q3 2017 was BlackRock, an estimated $80M sold.

Based on aggregated 13F filings for Q3 2017.